Clinical Trials Directory

Trials / Completed

CompletedNCT01203293

Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical Sector

CBT for Latinos With Generalized Anxiety Disorder in the General Medical Sector

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
90 (actual)
Sponsor
University of Puerto Rico · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this project is to implement culturally adapted Cognitive Behavioral Therapy (CBT) based interventions in general health settings that are delivered to reduce Generalized Anxiety Disorder (GAD) symptoms, increase levels of functioning, and improve health-related quality of life.

Detailed description

This project seeks to lay the foundation for an effectiveness trial that will lead to the advancement of CBT based treatments for GAD among Spanish-speaking Latinos, particularly Puerto Ricans. This area of research is important in light of the limited treatment options currently available for Spanish-speakers with GAD and the long-term negative consequences of this condition. Participants in this study are recruited in general health settings. Patients meeting criteria for enrollment will be randomly assigned to receive either cognitive behavior based therapy or treatment as usual. Assessments for all participants will be collected at baseline, post-treatment, and at two months follow-up visits.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive behavior based therapy15-20 individual psychotherapy sessions
BEHAVIORALTreatment as usualTreatment as usual is an active comparator group in which patients are provided referrals to specialty mental health care services or can use any primary or specialty care services available to them in usual care.

Timeline

Start date
2009-09-01
Primary completion
2013-02-01
Completion
2013-02-01
First posted
2010-09-16
Last updated
2014-08-28

Locations

1 site across 1 country: Puerto Rico

Source: ClinicalTrials.gov record NCT01203293. Inclusion in this directory is not an endorsement.